[儿科患者的神经肌肉阻塞]
概括
肌肉松剂在麻醉中至关重要,但婴儿和幼儿需要特定的,适应的给药方案. 这篇文章详细介绍了儿童麻醉的这些关键考虑因素.
科学领域:
- 麻醉学 麻醉学
- 儿科药理学 儿科药理学
- 关键护理医学 关键护理医学
背景情况:
- 肌肉松剂几十年来一直是麻醉的基石.
- 它们的使用是现代麻醉实践的组成部分.
- 专门的患者群体需要量身定制的药物管理方法.
研究的目的:
- 阐明在儿科患者中使用肌肉松剂时应考虑的具体因素.
- 为了突出婴儿和非常小的孩子接受麻醉所需的适应.
- 为儿童群体提供关于神经肌肉阻断剂安全有效使用的指导.
主要方法:
- 关于在儿科麻醉中使用肌肉松剂的现有文献的综述.
- 对婴儿和儿童的药理动力学和药理动力学差异的分析.
- 讨论儿科患者神经肌肉阻塞的临床挑战和最佳实践.
主要成果:
- 与成人相比,儿童患者对肌肉松剂的反应不同.
- 神经肌肉阻塞的剂量,发病,持续时间和逆转需要在新生儿和婴儿中仔细调整.
- 建议使用特定的药物和监测技术来优化安全性和疗效.
结论:
- 适应肌肉松剂的使用对于婴儿和幼儿的安全和有效麻醉至关重要.
- 了解儿科特异性生理学是管理神经肌肉阻塞的关键.
- 对优化儿科神经肌肉阻塞策略的进一步研究是有必要的.
相关概念视频
Nondepolarizing (Competitive) Neuromuscular Blockers: Pharmacological Actions
401
Nondepolarizing neuromuscular blockers prevent the membrane depolarization of muscle cells and inhibit muscle contraction. These are usually administered with anesthetics to achieve complete muscle relaxation. Upon administration, these drugs first block the small, rapidly contracting muscles of the face and hands, followed by the larger muscles of the trunk and the intercostal muscles. The diaphragm is the last muscle to be affected.
Although all competitive neuromuscular blockers are designed...
Although all competitive neuromuscular blockers are designed...
401
Nondepolarizing (Competitive) Neuromuscular Blockers: Mechanism of Action
1.7K
Nondepolarizing neuromuscular blockers induce paralysis by competitively blocking nicotinic acetylcholine receptors at the muscle end plate. Examples include pancuronium, mivacurium, vecuronium, and rocuronium. These quaternary ammonium derivatives are administered intravenously, are poorly absorbed, and are excreted via the kidneys.
Competitive antagonists prevent acetylcholine from binding to its receptor, inhibiting membrane depolarization. Without conformational changes or intrinsic...
Competitive antagonists prevent acetylcholine from binding to its receptor, inhibiting membrane depolarization. Without conformational changes or intrinsic...
1.7K
Neuromuscular Junction And Blockade
3.0K
The site of chemical communication between a motor neuron and a muscle fiber is called the neuromuscular junction (NMJ). The end of the motor neuron at the NMJ divides into a cluster of synaptic end bulbs. The cytoplasm of these bulbs consists of synaptic vesicles enclosing acetylcholine molecules, the principal neurotransmitter released at the NMJ. The region opposite the synaptic bulb that ends in the muscle fiber is called the motor end plate, which has acetylcholine receptors. Within the...
3.0K
Nondepolarizing (Competitive) Neuromuscular Blockers: Pharmacokinetics
437
All neuromuscular blocking agents are injected intravenously because they are poorly absorbed from the GI tract. Rapid onset is achieved with intravenous administration, although absorption is also adequate from an intramuscular injection. Since these agents are highly ionized, they do not readily penetrate cell membranes or cross the blood-brain barrier.
Instead, they are transported by the blood to different tissues. Muscles with a greater blood supply (arteries) and blood flow receive more...
Instead, they are transported by the blood to different tissues. Muscles with a greater blood supply (arteries) and blood flow receive more...
437
Skeletal Muscle Relaxants: Therapeutic Uses
477
Skeletal muscle relaxants are used to relax muscle tone and alleviate painful muscle contractions. However, the choice of skeletal muscle relaxants depends on the duration of the surgical procedure in order to minimize potential side effects. Skeletal muscle relaxants like neuromuscular blocking agents [NMBAs] are commonly employed as adjuvants alongside general anesthetics in clinical settings. NMBAs are also used to maintain controlled ventilation during surgery of the larynx or pharynx...
477
Depolarizing Blockers: Pharmocokinetics
315
Depolarizing blockers are administered through intravenous injection. Succinylcholine is the most common choice of depolarizing blockers in emergency clinical practices. Although they have a rapid onset, they readily diffuse away from the motor end plate into the extracellular fluid. They are metabolized by enzymes such as liver butyrylcholinesterase and plasma pseudocholinesterases. This produces a short duration of action, typically 5-10 minutes long, unlike nondepolarizing blockers, which...
315


